Jared Elenbaas, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinoblastoma Protein | 3 | 2018 | 671 | 0.860 |
Why?
|
| Cell Adhesion Molecules | 3 | 2023 | 1600 | 0.830 |
Why?
|
| Proteomics | 2 | 2023 | 3804 | 0.670 |
Why?
|
| Pancreas, Exocrine | 1 | 2018 | 48 | 0.600 |
Why?
|
| E2F Transcription Factors | 1 | 2018 | 269 | 0.580 |
Why?
|
| Lamin Type A | 1 | 2018 | 187 | 0.560 |
Why?
|
| Protoporphyria, Erythropoietic | 1 | 2016 | 55 | 0.500 |
Why?
|
| Blood Platelets | 2 | 2023 | 2522 | 0.500 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1395 | 0.310 |
Why?
|
| Drosophila | 1 | 2015 | 1491 | 0.290 |
Why?
|
| Homeostasis | 1 | 2018 | 3304 | 0.280 |
Why?
|
| Zebrafish | 3 | 2021 | 2996 | 0.270 |
Why?
|
| Uroporphyrins | 2 | 2021 | 4 | 0.240 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 3449 | 0.220 |
Why?
|
| Porphyria, Erythropoietic | 1 | 2021 | 10 | 0.190 |
Why?
|
| Cell Proliferation | 3 | 2022 | 10440 | 0.190 |
Why?
|
| Acitretin | 1 | 2021 | 16 | 0.190 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2022 | 1517 | 0.180 |
Why?
|
| Protoporphyrins | 2 | 2019 | 165 | 0.170 |
Why?
|
| Platelet Aggregation | 1 | 2023 | 800 | 0.170 |
Why?
|
| Porphyrias | 1 | 2019 | 58 | 0.170 |
Why?
|
| Lamins | 1 | 2018 | 37 | 0.160 |
Why?
|
| Nuclear Lamina | 1 | 2018 | 47 | 0.150 |
Why?
|
| Bone Development | 1 | 2021 | 472 | 0.150 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 18110 | 0.150 |
Why?
|
| Porphyrins | 2 | 2019 | 352 | 0.140 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 11908 | 0.140 |
Why?
|
| Ligands | 1 | 2023 | 3275 | 0.130 |
Why?
|
| Siderophores | 1 | 2016 | 61 | 0.130 |
Why?
|
| Atherosclerosis | 2 | 2022 | 3525 | 0.130 |
Why?
|
| Deferoxamine | 1 | 2016 | 153 | 0.130 |
Why?
|
| Acridine Orange | 1 | 2015 | 28 | 0.130 |
Why?
|
| Aminolevulinic Acid | 1 | 2016 | 142 | 0.120 |
Why?
|
| Animals | 12 | 2023 | 167838 | 0.120 |
Why?
|
| Larva | 1 | 2016 | 509 | 0.120 |
Why?
|
| Threonine | 1 | 2014 | 272 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2023 | 2822 | 0.110 |
Why?
|
| Mice | 8 | 2023 | 81138 | 0.110 |
Why?
|
| Photosensitizing Agents | 1 | 2016 | 608 | 0.100 |
Why?
|
| Bone and Bones | 1 | 2021 | 2560 | 0.090 |
Why?
|
| Serine | 1 | 2014 | 829 | 0.090 |
Why?
|
| DNA Primers | 1 | 2015 | 2817 | 0.090 |
Why?
|
| Lysine | 1 | 2014 | 1002 | 0.080 |
Why?
|
| Point Mutation | 1 | 2015 | 1594 | 0.080 |
Why?
|
| Gastrointestinal Diseases | 1 | 2018 | 1190 | 0.080 |
Why?
|
| Light | 1 | 2015 | 1343 | 0.080 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2022 | 684 | 0.070 |
Why?
|
| Liver | 3 | 2019 | 7514 | 0.070 |
Why?
|
| Phenotype | 1 | 2023 | 16532 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2022 | 1483 | 0.060 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 1698 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2015 | 5870 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 21981 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2018 | 14381 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 6649 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2022 | 695 | 0.040 |
Why?
|
| Dermatitis, Phototoxic | 1 | 2019 | 17 | 0.040 |
Why?
|
| Photosensitivity Disorders | 1 | 2019 | 80 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2022 | 673 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 829 | 0.040 |
Why?
|
| Heme | 1 | 2019 | 313 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2022 | 18968 | 0.030 |
Why?
|
| Humans | 8 | 2023 | 759255 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2018 | 23362 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2014 | 12106 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2015 | 531 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17750 | 0.030 |
Why?
|
| Cell Line | 2 | 2021 | 15636 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 2225 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2018 | 1167 | 0.030 |
Why?
|
| Protein Stability | 1 | 2014 | 566 | 0.030 |
Why?
|
| Cyclins | 1 | 2014 | 593 | 0.020 |
Why?
|
| Pancreas | 1 | 2018 | 1677 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 2558 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2014 | 656 | 0.020 |
Why?
|
| Eye | 1 | 2014 | 709 | 0.020 |
Why?
|
| Genome | 1 | 2018 | 1739 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2014 | 1552 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2019 | 3106 | 0.020 |
Why?
|
| Macrophages | 1 | 2022 | 5730 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 5039 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 2295 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 6053 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 4312 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8313 | 0.010 |
Why?
|
| Male | 2 | 2018 | 358719 | 0.010 |
Why?
|
| Female | 2 | 2018 | 390240 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 16871 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 29877 | 0.010 |
Why?
|